Clinical Trial Update: Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating lovastatin for mildly active rheumatoid arthritis was terminated; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-02-12